The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Fragoso YD, Boggild M, Macias-Islas MA, Carra A, Schaerer KD, Aguayo A, de Almeida SM, Alvarenga MP, Alvarenga RM, Alves-Leon SV, Arruda WO, Brooks JB, Comini-Frota ER, Ferreira ML, Finkelsztejn A, Finkelsztejn JM, de Freitas LD, Gallina AS, da Gama PD, Georgetto S, Giacomo MC, Gomes S, Gonçalves MV, Grzesiuk AK, Kaimen-Maciel DR, Lopes J, Lourenco GA, Malfetano FR, Morales NM, Morales Rde R, Oliveira CL, Onaha P, Patroclo C, Ribeiro SB, Ribeiro TA, Salminen HJ, Santoro P, Seefeld M, Soares PV, Tarulla A, Vasconcelos CC.
Fragoso YD, et al.
Clin Neurol Neurosurg. 2013 Feb;115(2):154-9. doi: 10.1016/j.clineuro.2012.04.024. Epub 2012 May 26.
Clin Neurol Neurosurg. 2013.
PMID: 22633835